Opinion

Video

The Evolvement of Imaging in ccRCC

Panelists discuss how cross-sectional imaging with pre- and postcontrast assessment remains the cornerstone of renal mass imaging, though newer software technologies now allow for better prediction of benign vs malignant tumors.

Video Player is loading.
Current Time 0:00
Duration 2:17
Loaded: 0%
Stream Type LIVE
Remaining Time 2:17
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Evolution of Imaging in Renal Cell Carcinoma (RCC)

    Main Discussion Topics:

    • Cross-sectional imaging with pre- and postcontrast assessment remains the cornerstone of renal mass evaluation.
    • Advanced software developments now allow for better assessment of images, potentially helping predict benign vs malignant masses.
    • Ongoing efforts to develop a “clear cell RCC score” based on MRI parameters to identify clear cell carcinoma vs benign tumors

    Key Points for Physicians:

    • Cross-sectional imaging with contrast remains essential for initial evaluation.
    • New software assessment tools may improve diagnostic accuracy.
    • Specialized MRI parameters show promise for distinguishing clear cell RCC from other masses.

    Notable Insights:

    The panel emphasized that although advanced imaging techniques are emerging, the fundamental approach of cross-sectional imaging with contrast has remained consistent for decades.

    Clinical Significance:

    New image processing technologies are enhancing traditional imaging modalities, potentially allowing for better risk stratification without increasing invasiveness.

    © 2025 MJH Life Sciences

    All rights reserved.